Malaria Vaccine Protects Children for More Than a Year
GlaxoSmithKline to develop vaccine commercially
An experimental malaria vaccine helps protect children for as long as 18 months against the deadly parasite, researchers report. The company that makes the vaccine, GlaxoSmithKline, says it will move ahead to develop the vaccine commercially.
It's not a home run by any stretch. The vaccine, called RTS,S, cut the number of cases in half after 18 months. Most childhood vaccines provide at least 90 percent protection. And it only reduced the number of cases in infants by a quarter.
But in the world of malaria vaccines, it's good enough. Researchers have worked for decades to try to make a vaccine against the malaria parasite, which is carried by mosquitoes. It has been especially difficult.
Malaria kills 660,000 people a year, mainly babies in the poorest parts of sub-Saharan Africa, and scientists say an effective vaccine is key to attempts to eradicate it.
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post comments
That is GOOD NEWS!
Screw Rachel Carson; some of those kids are gonna live anyhow.